Allopurinol as a kidney-protective, cardioprotective, and antihypertensive agent: Hype or reality?

Mehmet Kanbay, Yalcin Solak, Abduzhappar Gaipov, Mumtaz Takir, Daniel E. Weiner

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)

Abstract

Numerous experimental and clinical studies suggest that uric acid might have pathobiologic implications in the development and progression of hypertension, kidney disease, and coronary heart disease, among others, resulting in renewed interest in uric acid as a potential pathogenic mediator in these clinical conditions. Despite encouraging animal studies showing beneficial roles of allopurinol, clinical studies and randomized controlled trials remain scarce, and, despite available clinical evidence supporting a therapeutic role for allopurinol, multiple issues remain before routine use of allopurinol can be recommended for use in patients with hyperuricemia and hypertension, kidney disease, or coronary heart disease. These include a need for more robust clinical trial data that evaluate efficacy on hard clinical outcomes, optimal dose, duration of treatment, and the potential for serious allergic reactions. In this article we review the current available evidence describing the effects of allopurinol in hypertension, kidney disease, and coronary heart disease, highlighting unresolved issues surrounding allopurinol use for uric acid lowering in individuals without gout.

Original languageEnglish
Pages (from-to)172-178
Number of pages7
JournalBlood Purification
Volume37
Issue number3
DOIs
Publication statusPublished - Jan 1 2014
Externally publishedYes

Keywords

  • Allopurinol
  • Cardiovascular disease
  • Chronic kidney disease
  • Hypertension

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Fingerprint

Dive into the research topics of 'Allopurinol as a kidney-protective, cardioprotective, and antihypertensive agent: Hype or reality?'. Together they form a unique fingerprint.

Cite this